Literature DB >> 29728997

Formulation, Characterization, and Optimization of Captopril Fast-Dissolving Oral Films.

Fatemeh Rezaee1, Fariba Ganji2.   

Abstract

This work aimed to using optimization study to formulate a patient-friendly captopril fast-dissolving oral film with satisfactory disintegration time. Films were made with pullulan and hydroxypropyl methyl cellulose (HPMC) by using the solvent-casting method. Cellulose nanofiber (CNF) was used as a compatibilizer and glycerine was used as a plasticizer. In order to find an optimum formulation, a response surface methodology and a central composite design were employed. The concentration percentages of pullulan and glycerine were considered to be the design factors. Disintegration time, tensile strength, percent elongation at break, and folding endurance were considered to be the responses. The results showed that CNF improved the compatibility and tensile strength of the pullulan and HPMC blend. Also, the rigid nature of CNF reduced the film elongation but the addition of glycerine improved its flexibility. All formulations showed an acceptable uniformity content and dissolution rate. Complete dissolution for all formulations occurred within 2 min. Films with 26% pullulan, 74% HPMC, 1% CNF, and 5% glycerine were reported to be optimum formulations for captopril fast-dissolving oral films, with 95% confidence levels. The in vivo comparison of optimized formulation with a conventional captopril sublingual tablet exhibited significant increase in AUC (~ 62%) and Cmax (~ 52%) and a major decrease in Tmax (~ 33%). The overall results showed that the captopril FDF is a promising candidate for enhanced in vivo orotransmucosal absorption.

Entities:  

Keywords:  captopril; cellulose nanofiber; compatibilizer; optimization; oral film

Mesh:

Substances:

Year:  2018        PMID: 29728997     DOI: 10.1208/s12249-018-1027-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Fast-dissolving oral films containing dextromethorphan/phenylephrine for sinusitis treatment: formulation, characterization and optimization.

Authors:  Mozhgan Moonesan; Fariba Ganji; Arezoo Soroushnia; Fatemeh Bagheri
Journal:  Prog Biomater       Date:  2022-07-07

2.  Development and Characterizations of Pullulan and Maltodextrin-Based Oral Fast-Dissolving Films Employing a Box-Behnken Experimental Design.

Authors:  Kiramat Ali Shah; Binbin Gao; Robia Kamal; Anam Razzaq; Sun Qi; Qiu-Ning Zhu; Song Lina; Linyu Huang; Grainne Cremin; Haroon Iqbal; Farid Menaa; Jing-Hao Cui
Journal:  Materials (Basel)       Date:  2022-05-18       Impact factor: 3.748

3.  Construction of sublingual trilaminated Eszopiclone fast dissolving film for the treatment of Insomnia: Formulation, characterization and In vivo clinical comparative pharmacokinetic study in healthy human subjects.

Authors:  Mahmoud Teaima; Mohamed Yasser; Nehal Elfar; Kamel Shoueir; Mohamed El-Nabarawi; Doaa Helal
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

4.  Personalised 3D Printed Fast-Dissolving Tablets for Managing Hypertensive Crisis: In-Vitro/In-Vivo Studies.

Authors:  Amjad Hussain; Faisal Mahmood; Muhammad Sohail Arshad; Nasir Abbas; Nadia Qamar; Jahanzeb Mudassir; Samia Farhaj; Jorabar Singh Nirwan; Muhammad Usman Ghori
Journal:  Polymers (Basel)       Date:  2020-12-20       Impact factor: 4.329

5.  Formulation, characterization, optimization, and in-vivo performance of febuxostat self-nano-emulsifying system loaded sublingual films.

Authors:  Basant A Habib; Amina S Abd El-Samiae; Boushra M El-Houssieny; Randa Tag
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.